AU2002364385A1 - Implantable device and the use thereof - Google Patents

Implantable device and the use thereof

Info

Publication number
AU2002364385A1
AU2002364385A1 AU2002364385A AU2002364385A AU2002364385A1 AU 2002364385 A1 AU2002364385 A1 AU 2002364385A1 AU 2002364385 A AU2002364385 A AU 2002364385A AU 2002364385 A AU2002364385 A AU 2002364385A AU 2002364385 A1 AU2002364385 A1 AU 2002364385A1
Authority
AU
Australia
Prior art keywords
implantable device
implantable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002364385A
Other versions
AU2002364385A8 (en
Inventor
Thomas Brinker
Burkhard Schlosshauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NMI Naturwissenschaftliches und Medizinisches Institut
Original Assignee
NMI Naturwissenschaftliches und Medizinisches Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NMI Naturwissenschaftliches und Medizinisches Institut filed Critical NMI Naturwissenschaftliches und Medizinisches Institut
Publication of AU2002364385A1 publication Critical patent/AU2002364385A1/en
Publication of AU2002364385A8 publication Critical patent/AU2002364385A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0066—Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
AU2002364385A 2001-12-28 2002-11-28 Implantable device and the use thereof Abandoned AU2002364385A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10164039.0 2001-12-28
DE2001164039 DE10164039A1 (en) 2001-12-28 2001-12-28 Implantable device and its use
PCT/EP2002/013438 WO2003055411A2 (en) 2001-12-28 2002-11-28 Implantable device and the use thereof

Publications (2)

Publication Number Publication Date
AU2002364385A1 true AU2002364385A1 (en) 2003-07-15
AU2002364385A8 AU2002364385A8 (en) 2003-07-15

Family

ID=7710923

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002364385A Abandoned AU2002364385A1 (en) 2001-12-28 2002-11-28 Implantable device and the use thereof

Country Status (3)

Country Link
AU (1) AU2002364385A1 (en)
DE (1) DE10164039A1 (en)
WO (1) WO2003055411A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2602292A1 (en) * 2005-03-15 2006-09-21 The Regents Of The University Of California Method and system for modulating energy expenditure and neurotrophic factors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
JP3324782B2 (en) * 1991-05-31 2002-09-17 武田薬品工業株式会社 Expression promoter and its use
DE69430824T2 (en) * 1993-08-12 2003-01-23 Neurotech Sa Biocompatible immunoisolatory capsules that contain genetically modified cells
AU710504B2 (en) * 1994-03-15 1999-09-23 Brown University Research Foundation Polymeric gene delivery system
US5529066A (en) * 1994-06-27 1996-06-25 Cb-Carmel Biotechnology Ltd. Implantable capsule for enhancing cell electric signals
DE19529371C3 (en) * 1995-08-10 2003-05-28 Nmi Univ Tuebingen Microelectrode array
AU2002230999A1 (en) * 2000-12-21 2002-07-01 Medtronic, Inc. Electrically responsive promoter system

Also Published As

Publication number Publication date
WO2003055411A2 (en) 2003-07-10
DE10164039A1 (en) 2003-07-10
WO2003055411A3 (en) 2004-02-19
AU2002364385A8 (en) 2003-07-15

Similar Documents

Publication Publication Date Title
AU2003289463A1 (en) Luminescent body and optical device including the same
AU2002357643A1 (en) The human mob-5 (il-24) receptors and uses thereof
AU2002327185A1 (en) Diagnostic methods and devices
AU3620600A (en) Skin-marking devices and their use
AU2001298042A1 (en) Optimized pulsatile-flow ventricular-assist device and total artificial heart
AU2002351311A1 (en) Medical device
AU2001255522A1 (en) Mri-resistant implantable device
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2001256373A1 (en) Syringe and method for the use thereof
AU2841801A (en) Triazolotriazinones and the use thereof
AU2002343724A1 (en) Adhesive and use thereof
AU2002257724A1 (en) Cleaning device and its use
AU2002354070A1 (en) Medical polymers and use thereof
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU3278199A (en) Implantable device and use thereof
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
EP1367123A4 (en) Neurotonin and use thereof
AU2002364385A1 (en) Implantable device and the use thereof
GB2377179B (en) Magnotherapy device and use thereof
AU2002311066A1 (en) Electrophoresis device and the use thereof
AU2002333371A1 (en) Novel 4-aminofuropyrimidines and the use thereof
AU2001244832A1 (en) 3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
AU2001244831A1 (en) 3-cyclopentyloxy-4-methoxyphenyl-isoindolinone derivatives and the use thereof
AU2002228426A1 (en) Neurotonin and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase